[Adiponectin receptor regulation in diabetic states]

Area of Science:

• Metabolic diseases
• Endocrinology
• Molecular biology

Background:

• Adiponectin receptors mediate adiponectin's metabolic effects.
• Two receptors, AdipoR1 and AdipoR2, have been identified.
• Adiponectin plays a crucial role in glucose and lipid homeostasis.

Purpose of the Study:

• To investigate the expression patterns of AdipoR1 and AdipoR2 in diabetic and obese states.
• To explore the relationship between AdipoR1 expression and insulin levels.
• To elucidate the signaling pathway involved in AdipoR1 regulation by insulin.

Main Methods:

• Quantitative analysis of AdipoR1 and AdipoR2 expression in mouse models.
• Comparison of receptor expression in diabetic, obese, and lean mice.
• In vitro studies using C2C12 myocytes to assess insulin's effect on AdipoR1.
• Investigation of the phosphatidylinositol-3 kinase/Foxo 1 pathway.

Main Results:

• AdipoR1 expression was significantly elevated in insulin-deficient diabetic mice and decreased in insulin-resistant obese mice.
• AdipoR1 expression showed an inverse correlation with plasma insulin levels.
• Insulin treatment in vitro reduced AdipoR1 expression via the PI3K/Foxo 1 pathway.
• AdipoR2 expression remained largely unchanged in the studied diabetic conditions.

Conclusions:

• AdipoR1, but not AdipoR2, expression is dynamically regulated in response to diabetes and obesity.
• AdipoR1 regulation is linked to insulin levels and may play a role in metabolic dysregulation.
• The PI3K/Foxo 1 pathway is implicated in insulin-mediated AdipoR1 downregulation.